Zubsolv
- Product NDC
- 82111-206
- Requested package NDC
- 82111-206-30
- 11-digit product format
- 821110206
- Labeler code
- 82111
- Product ID
- 82111-206_57583c1d-9c44-4503-917d-68dba7377bd1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- buprenorphine hydrochloride and naloxone hydrochloride
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- SUBLINGUAL
- Labeler
- Edenbridge Pharmaceuticals LLC.
- Application
- NDA204242
- Marketing category
- NDA
- Marketing start
- 2026-06-12
- Substance
- BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
- Active strength
- 11.4; 2.9 mg/1; mg/1
- Pharmacologic classes
- Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204242-001 | ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | |
| N204242-002 | ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | |
| N204242-003 | ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | |
| N204242-004 | ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | |
| N204242-005 | ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 2.9MG BASE;EQ 0.71MG BASE | TABLET / SUBLINGUAL | RLD | 2015-06-04 | |
| N204242-006 | ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 0.7MG BASE;EQ 0.18MG BASE | TABLET / SUBLINGUAL | RLD | 2016-10-04 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204242-001 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2014-03-25 |
| N204242-001 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 |
| N204242-001 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | |
| N204242-001 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-001 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | |
| N204242-001 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | |
| N204242-001 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | |
| N204242-001 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | |
| N204242-002 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2014-03-25 |
| N204242-002 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 |
| N204242-002 | 10874661 | 2032-09-18 | Drug product | 2021-01-25 | |
| N204242-002 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | |
| N204242-002 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-002 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-002 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | |
| N204242-002 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | |
| N204242-002 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | |
| N204242-002 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | |
| N204242-003 | 8658198 | 2027-12-03 | U-1494 | Drug product | |
| N204242-003 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 |
| N204242-003 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | |
| N204242-003 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-003 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-003 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | |
| N204242-003 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | |
| N204242-003 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | |
| N204242-003 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | |
| N204242-004 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2015-01-09 |
| N204242-004 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 |
| N204242-004 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | |
| N204242-004 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-004 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-004 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | |
| N204242-004 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | |
| N204242-004 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | |
| N204242-004 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | |
| N204242-005 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2015-06-29 |
| N204242-005 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2015-06-29 |
| N204242-005 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | |
| N204242-005 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-005 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-005 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | |
| N204242-005 | 8940330 | 2032-09-18 | Drug product | 2015-06-29 | |
| N204242-005 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | |
| N204242-005 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | |
| N204242-006 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2016-10-26 |
| N204242-006 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2016-10-26 |
| N204242-006 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | |
| N204242-006 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 |
| N204242-006 | 8940330 | 2032-09-18 | Drug product | 2016-10-26 | |
| N204242-006 | 9259421 | 2032-09-18 | Drug product | 2016-10-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | ZUBSOLV | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | ZUBSOLV | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | ZUBSOLV | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | ZUBSOLV | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-005 | ZUBSOLV | EQ 2.9MG BASE;EQ 0.71MG BASE | TABLET / SUBLINGUAL | RLD | 2015-06-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-006 | ZUBSOLV | EQ 0.7MG BASE;EQ 0.18MG BASE | TABLET / SUBLINGUAL | RLD | 2016-10-04 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N204242-001 | ZUBSOLV | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204242-002 | ZUBSOLV | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204242-003 | ZUBSOLV | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204242-004 | ZUBSOLV | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204242-005 | ZUBSOLV | EQ 2.9MG BASE;EQ 0.71MG BASE | TABLET / SUBLINGUAL | RLD | 2015-06-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204242-006 | ZUBSOLV | EQ 0.7MG BASE;EQ 0.18MG BASE | TABLET / SUBLINGUAL | RLD | 2016-10-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204242-001 | ZUBSOLV | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204242-002 | ZUBSOLV | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204242-003 | ZUBSOLV | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204242-004 | ZUBSOLV | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204242-005 | ZUBSOLV | EQ 2.9MG BASE;EQ 0.71MG BASE | TABLET / SUBLINGUAL | RLD | 2015-06-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204242-006 | ZUBSOLV | EQ 0.7MG BASE;EQ 0.18MG BASE | TABLET / SUBLINGUAL | RLD | 2016-10-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204242-001 | ZUBSOLV | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204242-002 | ZUBSOLV | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204242-003 | ZUBSOLV | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204242-004 | ZUBSOLV | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204242-005 | ZUBSOLV | EQ 2.9MG BASE;EQ 0.71MG BASE | TABLET / SUBLINGUAL | RLD | 2015-06-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204242-006 | ZUBSOLV | EQ 0.7MG BASE;EQ 0.18MG BASE | TABLET / SUBLINGUAL | RLD | 2016-10-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204242-001 | ZUBSOLV | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204242-002 | ZUBSOLV | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204242-003 | ZUBSOLV | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204242-004 | ZUBSOLV | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204242-005 | ZUBSOLV | EQ 2.9MG BASE;EQ 0.71MG BASE | TABLET / SUBLINGUAL | RLD | 2015-06-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204242-006 | ZUBSOLV | EQ 0.7MG BASE;EQ 0.18MG BASE | TABLET / SUBLINGUAL | RLD | 2016-10-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204242-001 | ZUBSOLV | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204242-002 | ZUBSOLV | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204242-003 | ZUBSOLV | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204242-004 | ZUBSOLV | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204242-005 | ZUBSOLV | EQ 2.9MG BASE;EQ 0.71MG BASE | TABLET / SUBLINGUAL | RLD | 2015-06-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204242-006 | ZUBSOLV | EQ 0.7MG BASE;EQ 0.18MG BASE | TABLET / SUBLINGUAL | RLD | 2016-10-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204242-001 | ZUBSOLV | EQ 1.4MG BASE;EQ 0.36MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204242-002 | ZUBSOLV | EQ 5.7MG BASE;EQ 1.4MG BASE | TABLET / SUBLINGUAL | RLD | 2013-07-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204242-003 | ZUBSOLV | EQ 8.6MG BASE;EQ 2.1MG BASE | TABLET / SUBLINGUAL | RLD | 2014-12-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204242-004 | ZUBSOLV | EQ 11.4MG BASE;EQ 2.9MG BASE | TABLET / SUBLINGUAL | RLD, RS | 2014-12-11 | b8a1b40f171c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2014-03-25 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-001 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2014-03-25 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 10874661 | 2032-09-18 | Drug product | 2021-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-002 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 8658198 | 2027-12-03 | U-1494 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-003 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2015-01-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2013-07-10 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 11020388 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 11433066 | 2032-09-18 | U-3131 | 2022-09-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 8940330 | 2032-09-18 | Drug product | 2015-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 9259421 | 2032-09-18 | Drug product | 2016-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-004 | 9439900 | 2032-09-18 | Drug product | 2016-10-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-005 | 8658198 | 2027-12-03 | U-1494 | Drug product | 2015-06-29 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-005 | 8470361 | 2030-05-22 | U-1425 | Drug product | 2015-06-29 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N204242-005 | 10946010 | 2032-09-18 | Drug product | 2021-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204242-005 | 11020387 | 2032-09-18 | U-3131 | Drug product | 2021-06-21 | 84e616aacf4f… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Zubsolv
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BUPRENORPHINE HYDROCHLORIDE | 11.4 mg/1 |
| NALOXONE HYDROCHLORIDE | 2.9 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 56W8MW3EN1 | Internal UNII lookup |
| F850569PQR | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1431076 | Internal RxNorm lookup |
| 1431083 | Internal RxNorm lookup |
| 1431102 | Internal RxNorm lookup |
| 1431104 | Internal RxNorm lookup |
| 1597568 | Internal RxNorm lookup |
| 1597570 | Internal RxNorm lookup |
| 1597573 | Internal RxNorm lookup |
| 1597575 | Internal RxNorm lookup |
| 1666338 | Internal RxNorm lookup |
| 1666385 | Internal RxNorm lookup |
| 1864412 | Internal RxNorm lookup |
| 1864414 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57583c1d-9c44-4503-917d-68dba7377bd1 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zubsolv | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Edenbridge Pharmaceuticals LLC. | 57583c1d-9c44-4503-917d-68dba7377bd1 | 2026-06-12 | Warnings, Adverse reactions | 204242 NDA204242 82111-206-30 82111-206 82111020630 |
| Zubsolv | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Orexo US, Inc. | 5f5cfcfe-d52b-49e6-8fe4-550477332dd2 | 2025-12-27 | Warnings, Adverse reactions | 204242 NDA204242 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 82111-206-30 | 82111020630 | 3 BLISTER PACK in 1 CARTON (82111-206-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 3 blister pack | 2026-06-12 | No | No | Current |